Analgesic efficacy of oral dexketoprofen trometamol/tramadol hydrochloride versus tramadol hydrochloride/paracetamol: a randomised, double-blind, placebo and active controlled, parallel group study in moderate to severe acute pain after removal of impacted lower third molar

Trial Profile

Analgesic efficacy of oral dexketoprofen trometamol/tramadol hydrochloride versus tramadol hydrochloride/paracetamol: a randomised, double-blind, placebo and active controlled, parallel group study in moderate to severe acute pain after removal of impacted lower third molar

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Dexketoprofen trometamol (Primary) ; Tramadol/paracetamol
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms DAVID
  • Sponsors Menarini Ricerche
  • Most Recent Events

    • 11 Mar 2017 This trial has been completed in Poland (end date: 14 Feb 2017).
    • 25 Feb 2017 This trial has been completed in Hungary (end date: 14 Feb 2017).
    • 09 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top